Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{172221,
        author = {Soumitra Mandal},
        title = {Copper Nanoparticles in Cancer Care: From Bench to Bedside},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {11},
        number = {8},
        pages = {2335-2347},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=172221},
        abstract = {Copper nanoparticles (CuNPs) have emerged as a groundbreaking tool in cancer therapy, attributed to their exceptional physicochemical properties, biocompatibility, and versatility for multifunctional applications. They offer unique advantages such as high surface reactivity and the ability to be tailored for specific biological interactions, making them ideal for targeted cancer therapies and diagnostics. This review delves into the synthesis techniques, diverse mechanisms of action, and the wide array of therapeutic applications of CuNPs in oncology. Furthermore, it addresses the critical translational challenges, including toxicity, scalability, and regulatory barriers, which must be overcome to achieve clinical success. By effectively bridging the gap between innovative laboratory research and practical clinical implementation, CuNPs represent a transformative potential to revolutionize cancer care, paving the way for safer, more efficient, and personalized treatment strategies.},
        keywords = {Copper Nanoparticles, Nanomedicine Applications, Targeted Drug Delivery, Cancer Therapy, Photothermal and Chemotherapy.},
        month = {January},
        }